Abstract:Systemic lupus erythematosus (SLE) is a complex autoimmune disease with a strong genetic predisposition, characterized by an upregulated type I interferon pathway. MicroRNAs are important regulators of immune homeostasis, and aberrant microRNA expression has been demonstrated in patients with autoimmune diseases. We recently identified miR-146a as a negative regulator of the interferon pathway and linked the abnormal activation of this pathway to the underexpression of miR-146a in SLE patients. To explore why the expression of miR-146a is reduced in SLE patients, we conducted short parallel sequencing of potentially regulatory regions of miR-146a and identified a novel genetic variant (rs57095329) in the promoter region exhibiting evidence for association with SLE that was replicated independently in 7,182 Asians (Pmeta = 2.74610 , odds ratio = 1.29 [1.18–1.40]). The risk-associated G allele was linked to reduced expression of miR-146a in the peripheral blood leukocytes of the controls. Combined functional assays showed that the risk-associated G allele reduced the protein-binding affinity and activity of the promoter compared with those of the promoter containing the protective A allele. Transcription factor Ets-1, encoded by the lupus-susceptibility gene ETS1, identified in recent genomewide association studies, binds near this variant. The manipulation of Ets-1 levels strongly affected miR-146a promoter activity in vitro; and the knockdown of Ets-1, mimicking its reduced expression in SLE, directly impaired the induction of miR-146a. We also observed additive effects of the risk alleles of miR-146a and ETS1. Our data identified and confirmed an association between a functional promoter variant of miR-146a and SLE. This risk allele had decreased binding to transcription factor Ets-1, contributing to reduced levels of miR-146a in SLE patients. Citation: Luo X, Yang W, Ye D-Q, Cui H, Zhang Y, et al. (2011) A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus. PLoS Genet 7(6): e1002128. doi:10.1371/journal.pgen.1002128 Editor: Edward K. Wakeland, University of Texas Southwestern Medical Center, United States of America Received October 21, 2010; Accepted April 30, 2011; Published June 30, 2011 Copyright: 2011 Luo et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. Funding: This work was partially supported by the National Natural Science Foundation of China 30971632, 81025016; the National High Technology Research and Development Program of China (863 Program) 2007AA02Z123; the Program of the Shanghai Commission of Science and Technology 08JC1414700, 10JC1409300; the National Basic Research Program of China (973 Program) 2007CB947900 (to NS); the Program of the Shanghai Commission of Science and Technology 10ZR1434900 (to HC); the Research Grant Council of Hong Kong GRF HKU781709M (to WY); the National Natural Science Foundation of China 30830089 (to D-QY); and the US National Institutes of Health grant RO1AR043814 (to BPT). YLL thanks the generous donations from Shun Tak District Min Yuen Tong of Hong Kong. NH thanks the Higher Education Research Promotion and National Research University Project of Thailand, Office of the Higher Education Commission (HR1163A). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Competing Interests: The authors have declared that no competing interests exist. * E-mail: nanshensibs@gmail.com . These authors contributed equally to this work.

Lupus Risk-Variant Increases Pstat1 Binding and Decreases ETS1 Expression (BA4P.137)

Lupus Risk-Variant Increases Pstat1 Binding And Decreases Ets1 Expression

Genetic Variant at ETS1 Locus Increases Lupus Risk and Affects Stat1 Binding (BA2P.115)

Meta-analysis Followed by Replication Identifies Loci in or Near CDKN1B, TET3, CD80, DRAM1, and ARID5B As Associated with Systemic Lupus Erythematosus in Asians.

A Plausibly Causal Functional Lupus-Associated Risk Variant in the STAT1–STAT4 Locus

Lupus susceptibility region containing CTLA4 rs17268364 functionally reduces CTLA4 expression by binding EWSR1 and correlates IFN-α signature

Genome-Wide Association Study in Asian Populations Identifies Variants in ETS1 and WDFY4 Associated with Systemic Lupus Erythematosus

SLE Non-Coding Genetic Risk Variant Determines the Epigenetic Dysfunction of an Immune Cell Specific Enhancer That Controls Disease-Critical Microrna Expression

A Functional Variant in MicroRNA-146a Promoter Modulates Its Expression and Confers Disease Risk for Systemic Lupus Erythematosus

Global discovery of lupus genetic risk variant allelic enhancer activity

High-throughput identification of functional regulatory SNPs in systemic lupus erythematosus

Lupus Susceptibility Region Containing CDKN1B rs34330 Mechanistically Influences Expression and Function of Multiple Target Genes, Also Linked to Proliferation and Apoptosis

Lupus enhancer risk variant causes dysregulation of IRF8 through cooperative lncRNA and DNA methylation machinery

[Association of two SNPs in 3'UTR of ETS1 gene with systemic lupus erythematosus in a northern Chinese Han population].

Defining Mechanistic Links Between the Non-Coding Variant rs17673553 in CLEC16A and Lupus Susceptibility

modulates lupus risk via negative regulation of interferon response

Association of the Polymorphism Rs13259960 in SLEAR with Predisposition to Systemic Lupus Erythematosus

KLF2 enhancer variant rs4808485 increases lupus risk by modulating inflammasome machinery and cellular homoeostasis

The STAT4 SLE risk allele rs7574865[T] is associated with increased IL-12-induced IFN-γ production in T cells from patients with SLE

Gene-gene Interactions of IRF5, STAT4, IKZF1 and ETS1 in Systemic Lupus Erythematosus.